CONFIGURATION PARAMETERS Sample Clauses

CONFIGURATION PARAMETERS. (a) The initial model switch configuration consists of one 3B21 Administrative Module at 5E13 Base Generic, or the then available Generic, one CM2 Communications Module (two pairs), and two SM-2000 Switching Modules containing the following:
Sample 1Sample 2
AutoNDA by SimpleDocs
CONFIGURATION PARAMETERS. The DSP uses various configuration parameters controlled by the Core Processor. These configuration parameters specify frequencies, powers, durations, and thresholds used for detection and generation of tones and voice data. This section defines the various parameters and their format in DSP memory.
Sample 1
CONFIGURATION PARAMETERS. Configuration parameters in SAS Drug Development (screenshot below) define all aspects surrounding the program, which include all inputs, program “configuration” options and all outputs that need to be returned and saved to the repository. If you omit to specify an output, the output will not be moved to the repository after the program ends executing. A configuration parameter has several attributes that are specific to what input or output item it represents, but common to all is the name. A program can reference a configuration parameter in two different ways. A global macro variable with the configuration parameter name is automatically created, which value points to the temporary location on the SAS server. The configuration parameters LOG, LST and PGM may not be accessible through global macro variables, but can be obtained in the SAS Drug Development parameter data set as well as the original value of any configuration parameter. The special parameter data set is created for each execution of the full or just a selection of program code and contains all the original parameter values and other house-keeping properties. The data set is of course accessed by specifying the global macro variable SDDPARMS instead of the data set name. The configuration parameters are actually stored within and not separate to the program file in the repository as an eXtensible Markup Language (XML) structure appended to the end of each SAS program. The XML structure, in earlier versions of SAS Drug Development referred to as PACMAN, is interpreted each time a SAS program is executed within SAS Drug Development as the initialisation step. This XML structure remains well hidden from the user and is edited through one of the SAS Drug Development user interfaces, such as the Process Editor or Job Editor, rather than coded by the SAS Drug Development user. 1 The disconnect between the repository and SAS servers is until and including at least SAS Drug Development version 3.5. The difference between how programs are configured between the environments SAS Drug Development and SAS on a workstation or server prohibits a SAS program from being uploaded into SAS Drug Development from a local network share and executed without change. A next logical step is a simple convention that would allow a SAS program to work within and outside of SAS Drug Development and let the upload and download process complete any technical transformations necessary. PROGRAMS FOR BOTH An efficient proce...
Sample 1
CONFIGURATION PARAMETERS. Configuration parameters in SAS Drug Development (Display 1) define all aspects surrounding the program, which include all inputs, program “c nfiguration” options and all outputs that need to be returned and saved to the repository. If you omit to specify an output, the output will not be moved to the repository after the program ends executing.
Sample 1
CONFIGURATION PARAMETERS. To be executed the software requires the two configuration files containing parameters (i) for the control of the type of the susceptibility analysis to be performed (“configuration.txt”, Table 2), and (ii) for the spatial data configuration (“configuration_spatial_data.txt”, Table 3).
Sample 1

Related to CONFIGURATION PARAMETERS

  • Configuration The configuration for the Purchase Right Aircraft will be the Detail Specification for Model 767-3S2F aircraft at the revision level in effect at the time of the Supplemental Agreement. Such Detail Specification will be revised to include (i) changes required to obtain required regulatory certificates and (ii) other changes as mutually agreed upon by Boeing and Customer.

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Quality Specifications SANMINA-SCI shall comply with the quality specifications set forth in its Quality Manual, incorporated by reference herein, a copy of which is available from SANMINA-SCI upon request.

  • AIRCRAFT CONFIGURATION The guarantees defined in Paragraphs 2 and 3 below (the “Guarantees”) are applicable to the A321 Aircraft as described in the A321 Standard Specification ***** as amended by the following SCNs:

  • Changes to Specifications All Specifications and any changes thereto agreed to by the parties from time to time shall be in writing, dated and signed by the parties. Any change to the Packaging process shall be deemed a Specification change. No change in the Specifications shall be implemented by PCI, whether requested by Client, requested by PCI or requested or required by any Regulatory Authority, until the parties have agreed in writing to such change, the implementation date of such change, and any increase or decrease in costs, expenses or fees associated with such change (including any change to Pricing). PCI shall respond promptly to any request made by Client for a change in the Specifications, and both parties shall use commercially reasonable, good faith efforts to agree to the terms of such change in a timely manner. As soon as possible after a request is made for any change in Specifications, PCI shall notify Client of the costs associated with such change and shall provide such supporting documentation as Client may reasonably require. Client shall pay all costs associated with such agreed upon changes. If there is a conflict between the terms of this Agreement and the terms of the Specifications, this Agreement shall control. PCI reserves the right to postpone effecting changes to the Specifications, or in the case of changes requested or required by any Regulatory Authority postpone Packaging under this Agreement, until such time as the parties agree to and execute the required written amendment.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Specifications That part of the Contract Documents consisting of written requirements for materials, equipment, systems, standards, and workmanship as applied to the Work, and certain administrative requirements and procedural matters applicable thereto. The term "Specifications" shall also include all written matter in the Project Manual or on the drawings and any Addenda or Change Orders thereto.

  • Service Description The Parties will provide Common Channel Signaling (CCS) to one another via Signaling System 7 (SS7) network Interconnection, in accordance with prevailing industry standards. Use of a third party provider of SS7 trunks is permitted.

  • SERVICE LEVEL DESCRIPTION The Fund Accounting Agreement is hereby amended by deleting the Service Level Description attached thereto and replacing it in its entirety with the Service Level Description attached hereto.

  • Specification Changes Upon any change in the Product Specifications, stability protocols, QC laboratory methods raw material specification or Packaging Specifications (whether initiated by Horizon or made in response to a request by sanofi-aventis that is agreed to by Horizon), including the addition of new packaging configurations, new SKUs, new formulations, or a change in either raw materials or Packaging Component supply, Horizon shall promptly advise sanofi-aventis in writing of such changes, and sanofi-aventis shall promptly advise Horizon as to any scheduling and/or price adjustments which may result from such changes. Prior to implementation of such changes, the Parties shall negotiate in good faith in an attempt to reach agreement on (a) the new Product Price for any Product which embodies such changes, (b) any amounts to be reimbursed by Horizon to sanofi-aventis as described in the next sentence of this paragraph, and (c) any other amendments to this Agreement which may be necessitated by such changes (i.e., an adjustment to the lead time for purchase orders). Horizon shall reimburse sanofi-aventis for the mutually agreed upon reasonable expenses incurred by sanofi-aventis as a result of such changes, including, but not limited to, reimbursing sanofi-aventis for its mutually agreed validation and development costs, capital expenditure costs, costs for any Packaging Components or other materials rendered unusable as a result of such changes, and cost of required stability to support a change. If during the Term Horizon amends the Product Specifications or Packaging ***Confidential Treatment Requested MANUFACTURING AND SUPPLY AGREEMENT PAGE 7 Specifications (whether voluntarily or as required by law) so as to render obsolete quantities of the Active Ingredient, Excipients and/or Packaging Components for the Product on hand at sanofi-aventis, Horizon shall (i) accept the return of all such obsolete Active Ingredient and (ii) purchase from sanofi-aventis, at sanofi-aventis’ Acquisition Cost, all such obsolete Excipients and Packaging Components obtained by sanofi-aventis pursuant to its normal procurement policies to manufacture quantities of the Product pursuant to Horizon forecasts under Section 6.1. Sanofi-aventis’ normal procurement policies for purposes of the preceding sentence of this Article 5 shall be considered to be quantities of Excipients and Packaging Components corresponding to the immediately following […***…] months of Horizon’s most recent forecasted Product demand. If a change in Specifications is initiated by sanofi-aventis and approved by Horizon, any cost associated with said change shall be borne by sanofi-aventis. In the event that a change in Specifications is initiated by Horizon or driven by a regulatory or business change, the costs associated with qualification of the change shall be paid by Horizon. The amount of the change shall be reasonable and customary and subject to written approval by Horizon, such approval not to be unreasonably withheld. Sanofi-aventis, with written agreement and approval from Horizon, will be responsible for the appropriate (cGMP) destruction of any materials covered under this Article 5, and sanofi-aventis shall be reimbursed by Horizon at the reasonable and customary approved rate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!